Targeted self-assembly of functionalized carbon nanotubes on tumors
Patent
·
OSTI ID:1805418
Provided herein is the two component self-assembly single wall nanotube system and the single wall nanotube construct that is the second component. The two component self-assembly single wall nanotube system has a morpholino oligonucleotide with a targeting moiety followed by a single wall nanotube construct with second morpholino oligonucleotides complementary to the first morpholino oligonucleotides and one or both of a therapeutic or diagnostic payload molecule linked to the single wall nanotube construct.
- Research Organization:
- Memorial Sloan-Kettering Cancer Center, New York, NY (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- SC0002456;
- Assignee:
- Sloan-Kettering Institute for Cancer Research Inc. (New York, NY)
- Patent Number(s):
- 10,900,037
- Application Number:
- 15/985,775
- OSTI ID:
- 1805418
- Country of Publication:
- United States
- Language:
- English
Similar Records
Targeted self-assembly of functionalized carbon nanotubes on tumors
Method and composition for targeted delivery of therapeutic agents
Functionalized Single-Walled Carbon Nanotubes as Rationally Designed Vehicles for Tumor-Targeted Drug Delivery
Patent
·
2018
·
OSTI ID:1452898
Method and composition for targeted delivery of therapeutic agents
Patent
·
2021
·
OSTI ID:1860107
Functionalized Single-Walled Carbon Nanotubes as Rationally Designed Vehicles for Tumor-Targeted Drug Delivery
Journal Article
·
2008
· Journal of the American Chemical Society
·
OSTI ID:970412